Manufacturer People News from the 7/22 News Brief

MANUFACTURERS
Vitae Pharmaceuticals has named Martin Freed as chief medical officer. Freed spent nearly 14 years with GlaxoSmithKline and its predecessor, SmithKline Beecham Pharmaeuticals, most recently as vice president, clinical, in the company's Metabolism Therapeutic area were he led the clinical development of Avandia.

Wyeth has promoted Ulf Wiinberg to senior vice president of Wyeth and president of Wyeth Pharmaceuticals EMEA. Wiinberg was president of Wyeth consumer healthcare. Wiinberg has been with the Company since 1981. Also at Wyeth, Douglas Rogers was promoted to president, Wyeth consumer healthcare. His previous title was president, Wyeth consumer healthcare, U.S.
You must be a registered member of MMM to post a comment.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.

Email Newsletters


Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.